We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
- Authors
Pitt, B; Poole-Wilson, P A; Segal, R; Martinez, F A; Dickstein, K; Camm, A J; Konstam, M A; Riegger, G; Klinger, G H; Neaton, J; Sharma, D; Thiyagarajan, B
- Abstract
The ELITE study showed an association between the angiotensin II antagonist losartan and an unexpected survival benefit in elderly heart-failure patients, compared with captopril, an angiotensin-converting-enzyme (ACE) inhibitor. We did the ELITE II Losartan Heart Failure Survival Study to confirm whether losartan is superior to captopril in improving survival and is better tolerated.
- Publication
Lancet (London, England), 2000, Vol 355, Issue 9215, p1582
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(00)02213-3